Autopsy report · NCT06005662

Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“This study was de-prioritized in favor of the similar BIPOD-Out protocol due to a combination of practical considerations and expense. There are currently no plans to initiate this protocol.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: Johns Hopkins University
Sponsor type: University, hospital or other
Conditions: Opioid Use Disorder
Interventions: Psilocybin
Participants: 0
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.